40
Views
27
CrossRef citations to date
0
Altmetric
Review

Therapy for recurrent malignant glioma in adults

, , &
Pages 759-782 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Patrick Y Wen, Santosh Kesari & Jan Drappatz. (2006) Malignant gliomas: strategies to increase the effectiveness of targeted molecular treatment. Expert Review of Anticancer Therapy 6:5, pages 733-754.
Read now

Articles from other publishers (26)

Yuan Gao, Rui Wang, Tao Huang, Qilong Tian, Chen Yang, Younes Pilehvar & Julei Wang. (2023) Synthesis and characterization of rutin-loaded micelles for glioblastoma multiforme treatment: A computational and experimental study. Journal of Drug Delivery Science and Technology 86, pages 104675.
Crossref
Delia Cannizzaro & Adrian Safa. (2021) Letter to the Editor Regarding “Progress and Prospects of Recurrent Glioma: A Recent Scientometric Analysis of the Web of Science in 2019”. World Neurosurgery 151, pages 301.
Crossref
Yun Shao, Zhengxiang Yang, Weifeng Miao, Xiangrong Yu, Yiping Wu & Yi Pu. (2021) circ_0030018 promotes glioma proliferation and metastasis. Translational Neuroscience 12:1, pages 260-272.
Crossref
M. M. Sarycheva, A. V. Vazhenin, T. M. Sharabura, I. A. Vazhenin, E. Ya. Mozerova, A. A. Lozhkov, R. Yu. Karabut, A. T. Zhumabaeva, N. V. Kolyganova & T. A. Kopat. (2019) The role of a surgical component in the treatment of recurrent high-grade malignant gliomas. Onkologiya. Zhurnal imeni P.A.Gertsena 8:4, pages 271.
Crossref
Shenshan Zou, Yufu Zhu, Bin Wang, Fengyuan Qian, Xiang Zhang, Lei Wang, Chunling Fu, Hanmo Bao, Manyi Xie, Shangfeng Gao, Rutong Yu & Hengliang Shi. (2016) The Ubiquitin Ligase COP1 Promotes Glioma Cell Proliferation by Preferentially Downregulating Tumor Suppressor p53. Molecular Neurobiology 54:7, pages 5008-5016.
Crossref
Damian A. Almiron Bonnin, Cong Ran, Matthew C. Havrda, Huan Liu, Yasuyuki Hitoshi, Zhonghua Zhang, Chao Cheng, Matthew Ung & Mark A. Israel. (2017) Insulin-Mediated Signaling Facilitates Resistance to PDGFR Inhibition in Proneural hPDGFB-Driven Gliomas. Molecular Cancer Therapeutics 16:4, pages 705-716.
Crossref
Chawan Manaspon, Norased Nasongkla, Khuanjit Chaimongkolnukul, Pinunta Nittayacharn, Ketpat Vejjasilpa, Kanchana Kengkoom, Atthaporn Boongird & Suradej Hongeng. (2016) Injectable SN-38-loaded Polymeric Depots for Cancer Chemotherapy of Glioblastoma Multiforme. Pharmaceutical Research 33:12, pages 2891-2903.
Crossref
Pinunta Nittayacharn, Chawan Manaspon, Suradej Hongeng & Norased Nasongkla. (2014) HPLC analysis and extraction method of SN-38 in brain tumor model after injected by polymeric drug delivery system. Experimental Biology and Medicine 239:12, pages 1619-1629.
Crossref
Bangkim Chandra Khangembam, Sellam Karunanithi, Punit Sharma, Sudhir Suman Kc, Rajeev Kumar, Pramod Kumar Julka, Rakesh Kumar & Chandrasekhar Bal. (2014) Perfusion-metabolism coupling in recurrent gliomas: a prospective validation study with 13N-ammonia and 18F-fluorodeoxyglucose PET/CT. Neuroradiology 56:10, pages 893-902.
Crossref
Luju Liu & Yan Wang. (2014) A Mathematical Study of a TB Model with Treatment Interruptions and Two Latent Periods. Computational and Mathematical Methods in Medicine 2014, pages 1-15.
Crossref
Bangkim C. Khangembam, Punit Sharma, Sellam Karunanithi, Abhinav Singhal, Chandan J. Das, Praveen Kumar, Pramod K. Julka, Guru P. Bandopadhyaya, Rakesh Kumar, Arun Malhotra & Chandrasekhar Bal. (2013) 13N-Ammonia PET/CT for detection of recurrent glioma. Nuclear Medicine Communications 34:11, pages 1046-1054.
Crossref
Kai Li, Hongbin Han, Kai Zhu, Kejia Lee, Bo Liu, Fugen Zhou, Yu Fu & Qingyuan He. (2013) Real-time magnetic resonance imaging visualization and quantitative assessment of diffusion in the cerebral extracellular space of C6 glioma-bearing rats. Neuroscience Letters 543, pages 84-89.
Crossref
Lela Buckingham. 2013. Pharmacogenomics. Pharmacogenomics 117 131 .
Chawan Manaspon, Suradej Hongeng, Atthaporn Boongird & Norased Nasongkla. (2012) Preparation and in vitro characterization of SN-38-loaded, self-forming polymeric depots as an injectable drug delivery system. Journal of Pharmaceutical Sciences 101:10, pages 3708-3717.
Crossref
Santosh Kesari. (2011) Understanding Glioblastoma Tumor Biology: The Potential to Improve Current Diagnosis and Treatments. Seminars in Oncology 38, pages S2-S10.
Crossref
Timothy P. Dawson, Katherine Ashton, Aprajay Golash, Charles H. G. Davis, R. Venkat Iyer, Phil Roberts, Fred Harris & Robert W. Lea. (2011) Cell Survival Assays for Individualised Chemotherapy in Primary Glioma Cultures—Colourmetric or Luminescent?. Neuroscience and Medicine 02:04, pages 376-383.
Crossref
Murielle Mimeault & Surinder K Batra. (2011) Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy. Chinese Medicine 6:1, pages 31.
Crossref
Renukadevi Patil, Shivaputra Patil, XiangDi Wang, Fei Ma, William E. Orr, Wei Li, Charles R. Yates, Eldon E. Geisert & Duane D. Miller. (2010) Synthesis and evaluation of new 1,2,3,4-tetrahydroisoquinoline analogs as antiglioma agents. Medicinal Chemistry Research 20:1, pages 131-137.
Crossref
Jun-Ling Xu, Yong-Li Li, Jian-Min Lian, She-wei Dou, Feng-Shan Yan, Hui Wu & Da-peng Shi. (2010) Distinction between postoperative recurrent glioma and radiation injury using MR diffusion tensor imaging. Neuroradiology 52:12, pages 1193-1199.
Crossref
Daming Cui, Qiwu Xu, Ke Wang & Xiaoming Che. (2010) Gli1 is a potential target for alleviating multidrug resistance of gliomas. Journal of the Neurological Sciences 288:1-2, pages 156-166.
Crossref
Mia Carapancea, Oana Alexandru, Ani S. Fetea, Laura Dragutescu, Juan Castro, Ada Georgescu, A. Popa-Wagner, Magnus L. Bäcklund, Rolf Lewensohn & Anica Dricu. (2008) Growth factor receptors signaling in glioblastoma cells: therapeutic implications. Journal of Neuro-Oncology 92:2, pages 137-147.
Crossref
Ruty Mehrian ShaiJuergen KV ReichardtThomas C Chen. (2008) Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas. Future Oncology 4:4, pages 525-534.
Crossref
David A. Reardon & Patrick Y. Wen. (2006) Therapeutic Advances in the Treatment of Glioblastoma: Rationale and Potential Role of Targeted Agents. The Oncologist 11:2, pages 152-164.
Crossref
Santosh Kesari, Naren Ramakrishna, Claire Sauvageot, Charles D. Stiles & Patrick Y. Wen. (2006) Targeted molecular therapy of malignant gliomas. Current Oncology Reports 8:1, pages 58-70.
Crossref
Mark R. Gilbert & Monica Loghin. (2005) The treatment of malignant gliomas. Current Treatment Options in Neurology 7:4, pages 293-303.
Crossref
Santosh Kesari, Naren Ramakrishna, Claire Sauvageot, Charles D. Stiles & Patrick Y. Wen. (2005) Targeted molecular therapy of malignant gliomas. Current Neurology and Neuroscience Reports 5:3, pages 186-197.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.